Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

Overall survival (OS)

Overall survival is defined as the time from the date of inclusion to the date of death from any cause or to the date of last follow-up (in exceptional cases where it is impossible to document the date of death). Every effort should be made to document the cause of death.

Time frame: From date of randomization until the date of first documented progression assessed up to 120 months

Progression free survival

Progression free survival (PFS) will be measured from the date of inclusion to the date of progression or death, whatever the cause. Progression will be defined according to the RECIST criteria.

Time frame: From date of randomization until the date of first documented progression , assessed up to 120 months

Objective tumor response

Objective tumor response will be measured according to the RECIST 1.1 criteria.

Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months